CSF2 and chronic myelogenous leukemia, BCR-ABL1 positive: Our finding of an enhanced and prolonged mature phenotype after transduction of CML-DC by CD40-targeted, Ad-mediated GM-CSF gene transfer may have implications for CML-DC-based immunotherapeutic approaches.